Patents by Inventor Enrico Selvi

Enrico Selvi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS
    Publication number: 20180116999
    Abstract: This invention is in the field of medicinal chemistry and relates to novel compounds, and pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, Dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring/wound healing abnormalities, post operative adhesions, and reactive fibrosis. The invention also relates to methods of using the compounds and pharmaceutical compositions of this invention to treat fibrotic conditions.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 3, 2018
    Inventors: Robert B. ZURIER, Enrico SELVI
  • METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS
    Publication number: 20160367518
    Abstract: This invention is in the field of medicinal chemistry and relates to novel compounds, and pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, Dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring/wound healing abnormalities, post operative adhesions, and reactive fibrosis. The invention also relates to methods of using the compounds and pharmaceutical compositions of this invention to treat fibrotic conditions.
    Type: Application
    Filed: February 29, 2016
    Publication date: December 22, 2016
    Inventors: Robert B. Zurier, Enrico Selvi
  • METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS
    Publication number: 20120309820
    Abstract: This invention is in the field of medicinal chemistry and relates to novel compounds, and pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, Dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring/wound healing abnormalities, post operative adhesions, and reactive fibrosis. The invention also relates to methods of using the compounds and pharmaceutical compositions of this invention to treat fibrotic conditions.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 6, 2012
    Inventors: Robert B. Zurier, Enrico Selvi
  • Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
    Publication number: 20100173010
    Abstract: Soluble pharmaceutical composition for the treatment of articular pathologies comprising an effective amount of a least one linear or cyclic polymetaphosphate or a soluble and pharmaceutically acceptable salt thereof, and appropriate diluents.
    Type: Application
    Filed: December 21, 2004
    Publication date: July 8, 2010
    Applicant: UNIVERSITÁ DEGLI STUDI DI SIENA
    Inventors: Roberto Marcolongo, Manuela Catenaccio, Daniela Chindamo, Sauro Lorenzini, Enrico Selvi, Renzo Cini, Gabriella Tamasi, Michele Gregorkiewitz, Giovanni Cavallo